Bart B A, Gattis W A, Diem S J, O'Connor C M
Duke University Medical Center, Durham, North Carolina, USA.
Am J Cardiol. 1997 Apr 15;79(8):1118-20. doi: 10.1016/s0002-9149(97)00060-x.
We reviewed the records of 242 patients admitted over 1 year with heart failure and an ejection fraction < or = 45% to assess the use of angiotensin-converting enzyme inhibitors. Most patients were treated with angiotensin-converting enzyme inhibitors. However, an important minority (8%) had no apparent reason for the lack of this treatment, highlighting the need for strategies to increase the use of these beneficial agents.
我们回顾了242例在1年多时间里因心力衰竭入院且射血分数≤45%的患者的记录，以评估血管紧张素转换酶抑制剂的使用情况。大多数患者接受了血管紧张素转换酶抑制剂治疗。然而，有相当一部分（8%）患者没有明显原因未接受这种治疗，这凸显了采取策略以增加这些有益药物使用的必要性。
